|
|
|||||||||
EDITORIAL |
Dr. Freeman is Director, Center to Reduce Cancer Health Disparities, National Cancer Institute, Rockville, MD.
In 1971, President Richard Nixon signed the National Cancer Act and declared a "War Against Cancer." In the more than 30 years since this declaration of war, the nation has made extraordinary progress in our understanding of the causes of cancer, especially at the molecular level. We have also witnessed a dramatic evolution in the development of various therapeutic modalities resulting in more effective, more targeted, and less destructive cancer treatments. From a public health perspective, we have a seen a decline in the percentage of adults who smoke cigarettes. Note that tobacco is the cause of more than one third of cancer deaths. Related to this progress, an overall decline in cancer mortality has occurred in the last several years.
However, some Americans have not fully benefited from this progress as evidenced by their higher cancer incidence, mortality, and lower survival. Stating this another way, there is a critical disconnect between what we discover and what we deliver, between what we know and what we do for all people (Figure 1).1 It is critical to accurately define which groups of Americans suffer a heavier burden of cancer, determine the causes, and apply interventions to eliminate the disparities.
|
In this issue of CA, Ward and others highlight disparities in cancer incidence, mortality, and survival in relation to race/ethnicity and socioeconomic status.2 They conclude that for all cancer sites combined, residents of poorer counties have a higher cancer death rate than residents in more affluent counties. Ward further concludes that even when poverty rates are accounted for, some racial groups (eg, African Americans and American Indians/Alaskan Natives have a lower five-year survival rate than non-Hispanic Whites. Note also that within each racial/ethnic group, looked at separately, those living in poorer counties have the lowest survival rates according to Surveillance, Epidemiology, and End Results (SEER) Program data.
For a better understanding of the issues raised by Ward et al., it is important to review the background of our current knowledge of cancer disparities.
In 1973, Henschke noted an "alarming increase" in the cancer mortality in African Americans in the preceding 25 years.3 After the publication of this study, the National Cancer Institute (NCI) increased its focus on racial differences in cancer incidence, mortality, and survival. In 1986, based on a subcommittees findings, the American Cancer Society (ACS) issued a "Special Report on Cancer in the Economically Disadvantaged."4 The report concluded that the poorer cancer outcome in African Americans compared with White Americans is primarily related to lower socioeconomic status in African Americans. The study concluded further that poor Americans, irrespective of race, have a 10% to 15% lower five-year survival. A pivotal report by Freeman in 1989 provided an analysis and broad overview of these findings.5
In 1989, the ACS issued its report "Cancer in the Poor: A Report to the Nation."6 This report was the culmination of a series of fact-finding hearings held throughout the nation in collaboration with the NCI and Centers for Disease Control (CDC). Poor people with cancer of all racial and ethnic groups testified. The key findings were:
In 1990, McCord and Freeman determined that an African American male in Harlem has less of a chance of surviving to age 65 than a male in Bangledesh.7 Cancer was the number two cause of death in Harlem. The authors suggested that geographic areas of excess mortality should be delineated and targeted with special interventions to diminish mortality. The authors also recommended that geographic areas of extreme excess mortality, such as Harlem, justify special consideration analogous to that given to natural disaster areas.
In 1998, the Presidents Cancer Panel issued a report that concluded that the biological concept of race is untenable and has no legitimate place in biological science. The panel further concluded that racial injustice is a determinant of negative health outcomes. The panel challenged the entire scientific community to review the social values that shape its scientific perspectives with respect to race and to examine the biases and fundamental assumptions that scientists have made about the meaning of race in scientific investigation. Given the fact that populations do differ and that race in itself is not the determinant of such differences, the panel called for a serious dialogue in the scientific community to face the challenge of elucidating how populations really differ.8
The Institute of Medicine (IOM) issued two reports: The Unequal Burden of Cancer (1999)9 and Unequal Treatment (2003),10 which documented respectively the disproportionate cancer burden in African Americans and the fact that African Americans, even at the same economic and health insurance status, are less likely to receive the most curative treatment for cancer.
These landmark reports along with other important studies suggest that cancer disparities are driven by a complex set of social, economic, cultural, and health system factors.
Disease always occurs within the context of human circumstances, including social position, economic status, culture, and environment. To understand disparities in cancer incidence and outcome, there is a need to understand the circumstances in which cancer occurs. Poverty (low economic status), culture, and social injustice are believed to be the three principle determinants of cancer disparities. These factors are interrelated and, to some extent, superimposed. The relative effect of each of these factors changes with time and societal circumstances (refer to Figure 1 in Ward et al., this issue of CA).
| Poverty and Culture |
|---|
|
|
|---|
Who are the poor in America? According to the US Census Bureau in 2002, there were 285 million Americans, of whom 35 million (12%) were poor and 44 million (15%) were uninsured. A disproportionate percentage of African Americans (24%) and Hispanics/Latinos (22%) live below the poverty line compared with 8% of White Americans who are poor. Note that 25% of the poor are found within 12% of the population, which is African American (Figure 2). 11
|
Moreover, 20% of African Americans and 32% of Hispanics/Latinos but only 11% of Whites are medically uninsured (Figure 3). 12 Ward reports that residents who live in counties that have greater than 20% poor people have a 13% higher death rate in men and a 3% higher death rate in women. This is because poor as well as uninsured people are more likely to be treated for cancer at late stages of disease and are more likely to die from cancer.
|
What is the effect of culture? Culture is another critical factor influencing survival, but culture is not synonymous with race. Many cultures exist within any so-called racial group. Culture denotes a shared communication system; similarities in physical and social environment, common beliefs, values, traditions, and world view; and similarities in lifestyles, attitudes, and behavior. Culture is a powerful determinant of what diseases people will develop and how they will react to having a disease. The following examples will illustrate this point:
I theorize that poverty acts through the prism of culture. If this hypothesis is correct, then culture may augment or diminish povertys expected negative effects.
| Social Injustice/The Lens of Race |
|---|
|
|
|---|
I suggest that in this nation and perhaps throughout the world we see, value, and behave toward one another through a powerful lens of race.15 This lens can create false assumptions that may result in serious harm to members of some racial and ethnic groups. This phenomenon has been called racial profiling; we have seen it in cab drivers who bypass certain passengers and in policemen who search some people without apparent cause. Other examples are seen in the judicial system, housing, and, to some extent, in the field of medicine. Looking through the lens of race from the other direction, how do patients see health care professionals? If a patient does not trust his or her doctor or avoids participating in clinical trials for fear of being used as a "guinea pig," the patient too may be looking through the lens of race with possible detrimental results. False assumptions made based on a view from either side of this lens of race therefore can have profound effects on unequal treatments and health disparities.
| CONCLUSIONS |
|---|
|
|
|---|
Recommendations
We must tear down the economic, cultural, and societal barriers to early diagnosis and treatment of cancer. To win the war against cancer, we must apply what we know at any given time to all people. The designated battlegrounds for waging this war should include geographically and culturally delineated areas of high cancer mortality.
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Kobetz, A. Dunn Mendoza, J. Menard, L. Finney Rutten, J. Diem, B. Barton, J. Kornfeld, and N. McKenzie One Size Does Not Fit All: Differences in HPV Knowledge between Haitian and African American Women Cancer Epidemiol. Biomarkers Prev., February 1, 2010; 19(2): 366 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shariff-Marco, A. C. Klassen, and J. V. Bowie Racial/Ethnic Differences in Self-Reported Racism and Its Association With Cancer-Related Health Behaviors Am J Public Health, February 1, 2010; 100(2): 364 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hu, Y. Parmet, G. Allen, D. F. Parker, F. Ma, P. Rouhani, and R. S. Kirsner Disparity in Melanoma: A Trend Analysis of Melanoma Incidence and Stage at Diagnosis Among Whites, Hispanics, and Blacks in Florida Arch Dermatol, December 1, 2009; 145(12): 1369 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mosavel and T. Thomas Daughter-initiated health advice to mothers: perceptions of African-American and Latina daughters Health Educ. Res., October 1, 2009; 24(5): 799 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gerend and M. Pai Social Determinants of Black-White Disparities in Breast Cancer Mortality: A Review Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 2913 - 2923. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hu, R. M. Soza-Vento, D. F. Parker, and R. S. Kirsner Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in miami-dade county, Florida. Arch Dermatol, June 1, 2006; 142(6): 704 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kreps Communication and Racial Inequities in Health Care American Behavioral Scientist, February 1, 2006; 49(6): 760 - 774. [Abstract] [PDF] |
||||
![]() |
I. Jatoi, W. F. Anderson, S. R. Rao, and S. S. Devesa Breast Cancer Trends Among Black and White Women in the United States J. Clin. Oncol., November 1, 2005; 23(31): 7836 - 7841. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |